BioSpace News Archive

Business

Emergent BioSolutions to Release Second Quarter 2020 Financial Results and Conduct Conference Call on July 30, 2020

Emergent BioSolutions Inc. will host a conference call on Thursday, July 30, 2020 at 5:00 pm to discuss the financial results for the second quarter of 2020, recent business developments, revenue guidance for the third quarter of 2020, and financial outlook for full year 2020.

July 16, 2020
·
1 min read
Deals

BIOLASE Announces Expiration Of Oversubscribed Rights Offering

BIOLASE, Inc., a global leader in dental lasers, announced the expiration of the Company’s rights offering, which was oversubscribed.

July 16, 2020
·
5 min read
Biotech Bay

Clorox and Cleveland Clinic Partner to Address Public Health Needs Posed by COVID-19

The Clorox Company and Cleveland Clinic announced that they are bringing together their expertise to support public health as society continues to face COVID-19, while helping to instill confidence in the safety of public spaces among caregivers, patients, businesses and communities.

July 16, 2020
·
5 min read
Drug Development

New Preclinical Study Finds Niagen® Corrects Social Deficits in Mouse Model of Autism

First-of-its-kind preclinical study shows that Niagen® resolves social deficits and anxiety-like behaviors in male mice

July 16, 2020
·
6 min read
Business

Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020

Alexion Pharmaceuticals, Inc. announced that the Company will report its financial results for the second quarter ended June 30, 2020 before the US financial markets open on July 30, 2020.

July 16, 2020
·
1 min read
Business

Johnson & Johnson Reports 2020 Second-Quarter Results:

Sales of $18.3 billion reflecting a decline of 10.8%, operational decline of 9.0%* and adjusted operational decline of 8.8%*, primarily driven by the negative impact of the COVID-19 pandemic

July 16, 2020
·
13 min read
Policy

FDA Grants Priority Review to Merck’s New Drug Application for Vericiguat

Application Based on First Contemporary Outcomes Study Focused Exclusively on Chronic Heart Failure Patient Population Following a Worsening Event

July 16, 2020
·
6 min read
Pharm Country

Lannett And Cediprof Announce Exclusive Distribution Agreement For An Approved Levothyroxine

Lannett Company, Inc. and Cediprof, Inc., a part of the Neolpharma Pharmaceutical Group family of companies, said that the companies have entered into an interim exclusive supply and distribution agreement for Cediprof’s FDA approved Levothyroxine Sodium Tablets USP.

July 16, 2020
·
3 min read
Business

Agios to Webcast Conference Call of Second Quarter 2020 Financial Results on July 30, 2020

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, announced that the company will host a conference call and live webcast on Thursday, July 30, 2020 at 8:00 a.m.

July 16, 2020
·
1 min read
Pharm Country

Todos Medical Announces ANVISA Authorization in Brazil for 3D Med qPCR Kits and ANDis Extraction S

Todos Medical Ltd. announced that its partner supplier 3D Medicines Corporation has received authorization from the Brazilian Health Surveillance Agency to distribute its COVID-19 qPCR test kits and ANDis extraction systems.

July 16, 2020
·
4 min read